Ebolavirus Is Internalized into Host Cells Macropinocytosis in a Viral Glycoprotein-Dependent Manner
Ebolavirus (EBOV) is an enveloped, single-stranded, negative-sense RNA virus that causes severe hemorrhagic fever with mortality rates of up to 90% in humans and nonhuman primates. Previous studies suggest roles for clathrin- or caveolae-mediated endocytosis in EBOV entry; however, ebolavirus virions are long, filamentous particles that are larger than the plasma membrane invaginations that characterize clathrin- or caveolae-mediated endocytosis. The mechanism of EBOV entry remains, therefore, poorly understood. To better understand Ebolavirus entry, we carried out internalization studies with fluorescently labeled, biologically contained Ebolavirus and Ebolavirus-like particles (Ebola VLPs), both of which resemble authentic Ebolavirus in their morphology. We examined the mechanism of Ebolavirus internalization by real-time analysis of these fluorescently labeled Ebolavirus particles and found that their internalization was independent of clathrin- or caveolae-mediated endocytosis, but that they co-localized with sorting nexin (SNX) 5, a marker of macropinocytosis-specific endosomes (macropinosomes). Moreover, the internalization of Ebolavirus virions accelerated the uptake of a macropinocytosis-specific cargo, was associated with plasma membrane ruffling, and was dependent on cellular GTPases and kinases involved in macropinocytosis. A pseudotyped vesicular stomatitis virus possessing the Ebolavirus glycoprotein (GP) also co-localized with SNX5 and its internalization and infectivity were affected by macropinocytosis inhibitors. Taken together, our data suggest that Ebolavirus is internalized into cells by stimulating macropinocytosis in a GP-dependent manner. These findings provide new insights into the lifecycle of Ebolavirus and may aid in the development of therapeutics for Ebolavirus infection.
Published in the journal:
. PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001121
Category:
Research Article
doi:
https://doi.org/10.1371/journal.ppat.1001121
Summary
Ebolavirus (EBOV) is an enveloped, single-stranded, negative-sense RNA virus that causes severe hemorrhagic fever with mortality rates of up to 90% in humans and nonhuman primates. Previous studies suggest roles for clathrin- or caveolae-mediated endocytosis in EBOV entry; however, ebolavirus virions are long, filamentous particles that are larger than the plasma membrane invaginations that characterize clathrin- or caveolae-mediated endocytosis. The mechanism of EBOV entry remains, therefore, poorly understood. To better understand Ebolavirus entry, we carried out internalization studies with fluorescently labeled, biologically contained Ebolavirus and Ebolavirus-like particles (Ebola VLPs), both of which resemble authentic Ebolavirus in their morphology. We examined the mechanism of Ebolavirus internalization by real-time analysis of these fluorescently labeled Ebolavirus particles and found that their internalization was independent of clathrin- or caveolae-mediated endocytosis, but that they co-localized with sorting nexin (SNX) 5, a marker of macropinocytosis-specific endosomes (macropinosomes). Moreover, the internalization of Ebolavirus virions accelerated the uptake of a macropinocytosis-specific cargo, was associated with plasma membrane ruffling, and was dependent on cellular GTPases and kinases involved in macropinocytosis. A pseudotyped vesicular stomatitis virus possessing the Ebolavirus glycoprotein (GP) also co-localized with SNX5 and its internalization and infectivity were affected by macropinocytosis inhibitors. Taken together, our data suggest that Ebolavirus is internalized into cells by stimulating macropinocytosis in a GP-dependent manner. These findings provide new insights into the lifecycle of Ebolavirus and may aid in the development of therapeutics for Ebolavirus infection.
Introduction
Viruses have evolved a variety of mechanisms to enter host cells [1], [2], [3], including clathrin- and caveolae-mediated endocytosis, phagocytosis, and macropinocytosis. The main route of endocytosis, mediated by clathrin, is characterized by the formation of clathrin-coated pits (CCP) of 85–110 nm in diameter that bud into the cytoplasm to form clathrin-coated vesicles. Influenza virus, vesicular stomatitis virus (VSV) and Semliki forest virus all enter their host cells via this pathway [4], [5], [6]. Although Listeria monocytogenes is larger than a CCP in diameter, it exploits non-classical clathrin-mediated endocytosis along with actin rearrangement to facilitate its infection [7], [8]. Caveolae are small vesicles of 50–80 nm in diameter enriched in caveolin, cholesterol, and sphingolipid, and have been implicated in simian virus 40 (SV40) entry [9]. Clathrin- and caveolae-mediated endocytosis requires large guanosine tryphosphatases (GTPase) dynamin 2 for vesicle scission [3].
Phagocytosis plays a role in the uptake of microorganisms, cell debris, and apoptotic cells [10]. It is initiated by the interaction of cell surface receptors, such as mannose receptors, Fc receptors and lectin receptors, with their ligands at the surface of the internalized particles. Particles are internalized through a dynamin 2- and actin-dependent mechanism [11] that results in the formation of phagosomes, large particles of >500 nm in diameter. Human herpes simplex virus and acanthamoeba polyphaga mimivirus are internalized through this mechanism [12], [13].
Macropinocytosis is characterized by actin-dependent membrane ruffling and, unlike phagocytosis, was thought to be independent of receptors or dynamin 2 [14], [15], [16], [17]. Macropinocytosis is constitutively activated in some immune cells, such as dendritic cells and macrophages [18], [19], [20]. In the other cell types, including epithelial cells and fibloblasts, macropinocytosis is initiated by growth factor stimulation [21], [22] or expression of ruffling kinases [23], [24], [25]. Macropinocytosis is also associated with the activation of Rho GTPases, such as Rac1 and Cdc42, which are responsible for triggering membrane ruffles by actin polymerization [26], [27], [28], [29]. Macropinocytosis is dependent on a series of kinases; a serine/threonine p21-activated kinase 1 (Pak1) is activated by Rac1 or Cdc42 and is essential for the regulation of cytoskeleton dynamics [24], [30]. In addition Pak1 plays a role in macropinosome closure by activating carboxy-terminal-binding protein-1/brefeldin A-ADP ribosylated substrate (CtBP-1/BARS) [30]. Phosphatidylinositol-3-kinase (PI3K) and its effectors are responsible for ruffling and macropinocytosis [23], [31]. Protein kinase C (PKC) is activated by a receptor tyrosine kinase or PI3K and also promotes plasma membrane ruffling and macropinocytosis [23]. Membrane ruffling is associated with the formation of macropinocytosis-specific endosomes, macropinosomes, of approximately 0.5–10 µm in diameter [32]. Human adenovirus type 3 (Ad3) [33], vaccinia virus [26], Kaposi's Sarcoma Associated Herpesvirus [34], and Nipah virus [35] enter cells via macropinocytosis. Human immunodeficiency virus (HIV) [36], [37] and Ad2/5 [38] may also trigger this pathway.
Ebolavirus (EBOV) is an enveloped, single-stranded, negative-sense RNA virus that belongs to the family Filoviridae. In humans and nonhuman primates, it causes severe hemorrhagic fever with mortality rates of up to 90%. Ebolavirus virions are long, filamentous particles of varied length (typically, 1–2 µm) and a diameter of 80–100 nm. EBOV infects a wide range of host cells [39], suggesting that its entry into target cells is mediated by the binding of its surface glycoprotein (GP) to a widely expressed and highly conserved receptor, or by GP binding to different host receptors. Several cellular proteins have been reported as EBOV receptors or co-receptors, including folate receptor-α (FR-α) [40], several lectins [41], [42], [43], [44], [45], [46], and integrin ß1 [47]. In addition, EBOV entry is facilitated by members of the Tyro3 protein kinase family [48], [49].
The mechanism of EBOV cell entry is currently poorly understood. EBOV is likely internalized by an endocytic pathway, since its entry is dependent upon low pH [50], [51] and the endocytic enzymes cathepsin B and L [52], [53], [54], [55], [56]. Several studies suggest that EBOV internalization depends on cholesterol, a major component of caveolae and lipid-rafts [50], [57], [58]. Another study suggests a role for clathrin-mediated endocytosis in wild-type EBOV and retrovirus psendotyped with EBOV GP entry [59], [60]. These discrepancies may reflect differences in the experimental systems and/or conditions used. Most studies have been carried out with retroviruses or vesicular stomatitis virus (VSV) pseudotyped with EBOV GP [52], [53], [54], [56], [58], [61]. These pseudotyped systems have limitations because the morphology of the virions differs significantly from that of authentic Ebola virions (spherical for retrovirus or VSV-pseudotyped virions versus filamentous for authentic Ebola virions).
To better understand EBOV entry, we conducted internalization studies with fluorescently labeled, biologically contained EBOV [62], and Ebolavirus-like particles (Ebola VLPs), both of which resemble authentic EBOV in their morphology [62], [63], [64], [65]. Our results suggest that EBOV uptake into cells involves the macropinocytic pathway and is GP-dependent.
Results
Internalization of fluorescently labeled Ebola virions and Ebolavirus-like particles (Ebola VLPs)
To assess the mechanism of EBOV entry, we established a real-time monitoring system for fluorescently labeled, biologically contained Ebola virions [62], and fluorescently labeled Ebola VLPs [63], [64], [65]. The biologically contained EBOV (EbolaΔVP30) lacks the gene for the viral transcriptional co-activator VP30 and can only replicate in VP30-expressing cells [62]. EbolaΔVP30 resembles authentic EBOV [62] and thus provides an ideal system to study EBOV entry. Likewise, co-expression of the EBOV GP glycoprotein and the VP40 matrix protein yields virus-like particles (VLPs) with filamentous architecture [63], [64], [65]. Since co-expression of the EBOV nucleoprotein (NP) increases the efficiency of VLP generation [66], we generated VLPs by co-expressing GP, VP40, and NP. To establish a real-time monitoring system for EBOV cell entry, EbolaΔVP30 virions and Ebola VLPs were generated and purified as described in the Material and Methods, and labeled with a lipophilic tracer, 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI), which is incorporated into the envelope of the virions [67], [68], [69]. The infectivity of DiI-labeled EbolaΔVP30 was equivalent to that of unlabeled virions as measured by plaque assays (data not shown), demonstrating that DiI labeling did not interfere with virion binding and infectivity.
We synchronized the adsorption of DiI-labeled EbolaΔVP30 and Ebola VLPs to African green monkey kidney epithelial (Vero) cells, which support EBOV replication, for 30 min on ice. We assessed the effect of low temperature incubation on the internalization of the DiI-virions by incubation on ice, room temperature, or 37°C in parallel, followed by a temperature shift to 37°C and found that there were no appreciably differences in the total numbers of internalized virions across these conditions, suggesting that incubation of cells and virions on ice had a limited effect on the subsequent viral internalization (Figure S1).
After adsorption, we shifted the temperature to 37°C and visualized the labeled particles by using confocal laser scanning microscope at various times. DiI-labeled EbolaΔVP30 and Ebola VLPs were visualized as red particles of various sizes (red, Figure S2A), indicating that viral particles of various lengths had been produced, an observation that we confirmed by electron microscope (Figure S3). Both DiI-labeled EbolaΔVP30 and Ebola VLPs were internalized efficiently, migrated immediately after the temperature shift, and eventually trafficked to intracellular compartments (Figure S2A and B, left panels, Video S1). As a control, we tested VLPs that lacked GP [Ebola VLPs (-GP)]. These particles bound to the cells with low efficiency and remained stationary even after long-term incubation at 37°C (Figure S2A and B, right panels, Video S2), confirming the requirement of GP for binding and internalization of EBOV.
Role of clathrin-mediated endocytosis in EBOV entry
Previous studies suggested that EBOV enters cells via clathrin-mediated endocytosis [50], [59]. The typical architecture of Ebola virions (length 1–2 µm and diameter 80–100 nm) is larger than the diameter of clathrin-coated pits (85–110 nm). However, Listeria monocytogenes is internalized into cells via non-classical clathrin-mediated endocytosis [7], [8], Therefore, we visualized clathrin-coated pits (CCPs) via the expression of clathrin light chain a (CLCa) fused to enhanced green fluorescent protein (eGFP) to assess the significance of this pathway for EBOV internalization. The functional integrity of clathrin is not compromised by fusion to eGFP and the expressed fusion protein forms CCPs with endogenous CLCa [70], [71]. We did not detect co-localization of eGFP-labeled CLCa (CLCa-eGFP) with DiI-labeled EbolaΔVP30 virions (Figure 1A, left panel and Video S3) or Ebola VLPs (Figure 1A, right panel) at 15 min or 60 min after the temperature shift, whereas fluorescence-labeled Transferrin (Tf), a specific ligand of the clathrin-mediated pathway, was co-localized with eGFP-CLCa (Figure S4, left panel). These results suggest that clathrin-mediated endocytosis may not be critical for EBOV entry.
To further assess the role of clathrin-dependent endocytosis in EBOV entry, we down-regulated endogenous clathrin heavy chain (CHC) with small interfering RNAs (siRNA) and assessed the effect of CHC down-regulation on the internalization of Ebola virions. Down-regulation of CHC expression (red) was confirmed by immunofluorescent staining in Vero cells (Figure 1B, lower right panel). To remove the surface-bound uninternalized virions, we treated the cells with trypsin 2 h post-temperature shift (Figure S5). The uptake of Alexa Fluor-Tf was abrogated in CHC siRNA-treated cells, indicating that the clathrin-mediated endocytosis was blocked in these cells (Figure 1B, lower right panel). However, internalization of Ebola VLPs was not blocked by down-regulation of CHC (Figure 1B, upper right panel and Figure 1C), further suggesting that clathrin-mediated endocytosis is not critical for EBOV entry.
Role of caveolin-mediated endocytosis in EBOV entry
Previous studies also indicated a role for caveolin-mediated endocytosis in EBOV internalization [50], [59]. Using a similar strategy to that described above, we assessed the co-localization of eGFP-fused caveolin 1 (Cav1-eGFP), which does not impair the internalization of caveolae [9], [72], with DiI-labeled EbolaΔVP30 (Figure 2A, left panel, Video S4) and Ebola VLPs (Figure 2A, right panel). We did not observe efficient co-localization of labeled Ebola virions with Cav1, indicating that caveolaes may not play a critical role in EBOV entry. Alexa Fluor-Chorela toxin B subunit (CtxB), which is internalized via caveolae- and clathrin-mediated endocytosis [73], was co-localized with some of the Cav1-eGFP (Figure S4, right panel).
The role of caveolin-mediated endocytosis was further tested by inhibiting Cav1 expression with siRNA. Down-regulation of Cav1 expression was confirmed by immunofluorescent staining and western blotting in Vero cells (Figure 2B, lower right panel). Cav1 down-regulation did not prevent DiI-Ebola VLP internalization (Figure 2B and 2C), upper right panel and Figure 2D), further suggesting that caveolin-mediated endocytosis does not play a critical role in EBOV internalization. Our finding that DiI-labeled EbolaΔVP30 virions enter Cav1-deficient human hepatoblastoma Huh7 cells [74] (Figure 2E) further supports this concept.
Clathrin-, caveolae- and phagocytosis-mediated endocytosis all depend on dynamin 2, a large GTPase that plays an essential role in vesicle scission during clathrin- and caveolae-dependent endocytosis and phagocytosis [75]. Treatment with a dynamine-specific inhibitor, dynasore [76], reduced the internalization of Alexa Fluor-labeled Tf (green; Figure 2F, right panel); however, dynasore did not affect the internalization of DiI-labeled virions (Figure 2F, right panel and Figure 2G). These data indicate that EBOV internalization does not involve clathrin-, caveolin-, or phagocytosis-mediated endocytosis.
Ebola virions co-localize with sorting nexin (SNX) 5, a component of macropinosomes
Our data argue against a role for clathrin-, caveolae-, or phagocytosis-mediated endocytosis in the internalization of EBOV. We therefore considered macropinocytosis as a potential mode of EBOV entry. Induction of macropinocytosis leads the formation of macropinocytosis-specific endosomes (macropinosomes), which are large enough (0.5–10 µm of diameter) [32] to accommodate Ebola virions.
Sorting nexin (SNX) 5 comprises a large family of peripheral membrane proteins that associate with newly formed macropinosomes and are involved in their maturation [77], [78]. To assess the role of macropinocytosis in EBOV internalization, we first generated Vero cells expressing an eGFP-SNX5 fusion protein and confirmed that a specific ligand of macropinocytosis, dextran Mw 10,000 (Dex Mw 10K) co-localized with expressed eGFP-SNX5 (Figure S6A) but not with CLCa-eGFP or Cav1-eGFP in Vero cells (Figure S6B). We then asked whether DiI-labeled EbolaΔVP30 and Ebola VLPs co-localize with eGFP-SNX5-positive vesicles. Approximately 70% of DiI-labeled EbolaΔVP30 (blue bars in Figure 3B) and 45% of DiI-labeled Ebola VLPs (yellow bars in Figure 3B) associated with eGFP-SNX5-positive vesicles within 10 min of the temperature shift to 37°C (Figure 3A, upper panels, Figure 3B, and Video S5). Co-localization of viral particles with eGFP-SNX5-positive vesicles continued for 30 min after the temperature shift and then decreased (Figure 3B). On the other hand, DiI-labeled influenza viruses, which are mainly internalized by clathrin-mediated endocytosis [5], did not appreciably co-localize with eGFP-SNX5-positive vesicles (Figure 3A, red bars in lower panels, Figure 3B, and Video S6). We further confirmed co-localization of Ebola VLPs with endogenous SNX5 (Figure S7A). These observations suggest an association of internalized Ebola virions with macropinosomes.
Internalized DiI-labeled Ebola virions traffic to endosomal compartments
Once internalized, macropinosomes mature into endocytic vesicles [77], [79]. However, the endocytic pathway is also part of the clathrin- and caveolin-mediated entry processes. Several groups have shown that authentic EBOV and EBOV GP-pseudotyped virions enter cells in a low pH- and cathepsin B/L-dependent manner, consistent with endosomal entry [50], [51], [52], [53], [54], [55], [56]. Here, we sought to confirm endosomal localization of EbolaΔVP30 and Ebola VLPs, both of which more closely resemble authentic EBOV than do pseudotyped viruses.
The small GTPase Rab7 specifically associates with late endosomes [80], [81] and serves as a marker for this compartment. We, therefore, analyzed the co-localization of internalized DiI-labeled virions with eGFP-Rab7-positive vesicles after the temperature shift. About 20% of DiI-labeled EbolaΔVP30 virions (blue bars in Figure 4B) and Ebola VLPs (yellow bars in Figure 4B) co-localized with eGFP-Rab7 within 10–20 min of the temperature shift; within 2 h of the temperature shift, 70%–80% of EbolaΔVP30 particles and Ebola VLPs co-localized with eGFP-Rab7 (Figure 4A and 4B). Internalized Dex Mw 10K, a specific ligand of macropinocytosis, was also observed in Rab7-positive vesicles (Figure S8). We further confirmed co-localization of Ebola VLPs with endogenous Rab7 (Figure S7B). At 3–4 h after the temperature shift, the DiI-signals were enlarged and overlapped with eGFP-Rab7 (Figure S9, left panel), suggesting fusion of the DiI-labeled viral envelopes with endosomal membranes. Following treatment with NH4Cl, which inhibits the acidification of endosomes, the DiI-signals localized with eGFP-Rab7 but remained small (Figure S9, right panel), indicating that NH4Cl inhibited membrane fusion. Similarly, VLPs possessing a fusion-deficient GP mutant (F535R) [82] trafficked to eGFP-Rab7-positive vesicles but the signals remained small (Figure S10). Collectively, these findings indicate that internalized EBOV particles are transported to late endosomes, where low pH-dependent membrane fusion occurs.
Inhibitors of macropinocytosis interfere with EBOV internalization
To further test whether Ebola virions are internalized via macropinocytosis, we assessed several inhibitors for their effects on EBOV uptake. DiI-labeled influenza virus particles which are internalized via clathrin-mediated endocytosis, served as a control. An actin depolymerizing agent, cytochalasin D (CytoD) was used because macropinocytosis depends on actin bundle formation; however, an intact actin skeleton is also critical for other endocytic pathways [83]. Since macropinocytosis relies on PI3K activation [23], [31], we also tested two inhibitors of this kinase, wortmannin (Wort) and LY-294002 [84]. Finally, we used EIPA [5-(N-ethyl-N-isopropyl) amiloride], an inhibitor of the Na+/H+ exchanger that specifically inhibits macropinocytosis [26], [34], [35], [85], [86]. These inhibitors all inhibited the uptake of Dex Mw 10K (Figure S11A and B). Treatment of cells with the inhibitors appreciably blocked co-localization of EbolaΔVP30 (blue bars in Figure 5B) and VLPs (yellow bars in Figure 5B) with late endosomes, as visualized by eGFP-Rab7 expression (Figure 5A and 5B). CytoD treatment also affected co-localization of DiI-labeled influenza virus with late endosomes (red bars in Figure 5B and S12); this observation was expected because actin is also critical for the internalization of influenza viruses [69], [72], [87]. Entry of influenza virus was also moderately affected by the PI3K inhibitors (Figure 5B and S12), a result consistent with a previous report of PI3K-dependent influenza virus cell entry [88]. However, the internalization of influenza virus was not inhibited by EIPA (Figures 5B and S11), whereas the uptake of DiI-EbolaΔVP30 and Ebola VLPs was appreciably reduced in the presence of this compound (Figure 5A and 5B). These findings suggest that EBOV is internalized via macropinocytosis.
Macropinocytosis-associated events occur during Ebola virion internalization
Constitutive macropinocytosis occurs in specific cell types such as dendritic cells and macrophages [18], [19], [20]; however, in epithelial cells, it is initiated in response to growth factor stimulation [21], [22] or expression of ruffling kinases [23], [24], [25]. To assess whether Ebola virions activate macropinocytosis to allow EBOV be internalized into the cells, we asked whether the virions accelerated the uptake of a macropinocytosis marker, Dex Mw 10K. In the presence of Ebola virions, the uptake of Dex Mw 10K was accelerated (Figure 6A and S13), and this event was inhibited by EIPA. Co-localization of DiI-EbolaΔVP30 and Alexa Fluor-Dex Mw 10K was also observed (Figure 6B).
The Rho GTPases (Rac1 and Cdc42), protein kinase C (PKC), and Pak1 are involved in the regulation of macropinocytosis[23], [24], [27], [29], [30]. Therefore, we examined the role of Rac1 by use of dominant-negative Rac1 (dnRac1) [89]. Expression of eGFP-fused dnRac1 inhibited the internalization of Ebola virions (red) into cells by 80% (Figure 6C, lower right panel; Figure 6D) compared with that of eGFP-fused wild-type Rac1 (wtRac1) (Figure 6C upper right panel; Figure 6D). dnRac1 expression also interfered with the uptake of Dex Mw 10K (blue) (Figure 6C, lower middle panel), indicating that expression of dnRac1 inhibited macropinocytosis. The role of PKC in the internalization of Ebola virions was tested by use of the specific PKC inhibitor staurosporine [90]. Staurosporine reduced the internalization of DiI-virions (red bars in Figure 6E and left panels in Figure S14A) and Dex Mw 10K (blue bars in Figure 6E and right panels in Figure S14A) by 80% and 70%, respectively. The effect of down-regulation of Cdc42, and Pak1 by siRNAs on Ebola VLP uptake was also tested. Down-regulation at the mRNA level was assessed by RT-PCR (Figure 6F). Knockdown of Cdc42 and Pak1 appreciably interfered with DiI-Ebola VLP internalization (red bars in Figure 6G and left panels in Figure S14B) and also reduced the uptake of Dex Mw 10K (blue bars in Figure 6G and right panels in Figure S14B). Since plasma membrane ruffling precedes macropinocytosis [14], [15], [16], we monitored ruffling formation in the internalization of DiI-virions by use of Vero cells expressing eGFP-actin [91]. Time-lapse analysis revealed that prominent plasma membrane ruffling was associated with DiI-labeled virions after the temperature-shift (Figure 6H and Video S7). Appreciable actin rearrangement was not observed in the absence of EBOV virions (Figure S15 and Video S8). Together, these results demonstrate that Ebola virions stimulate macropinocytosis along with the activation of the cellular factors involved in actin polymerization that allow the virions to be internalized.
Internalization of EBOV particles is GP-dependent
Our data indicate that the EBOV particle internalization occurs via macropinocytosis, whereas previous studies suggest that clathrin- or caveolin-dependent endocytosis mediate the internalization of wild-type EBOV and EBOV GP-pseudotyped VSV or retroviruses [50], [57], [58], [59]. To determine if these conflicting findings result from differences in assay systems (i.e., use of pseudotype viruses) and/or experimental conditions used, we tested whether a VSV pseudotyped with EBOV GP (VSVΔ*G-GP) was internalized by macropinocytosis. Although VSV is known to be internalized via the clathrin-dependent pathway [6], DiI-labeled VSVΔ*G-GP virions did not co-localize with CLCa-eGFP or Cav1-eGFP (Figure S16), whereas DiI-labeled VSVΔ*G-G virions co-localized with CLCa-eGFP (Figure S17). By contrast, DiI-labeled VSVΔ*G-GP virions co-localized with eGFP-SNX5 (Figure 7A, left panel), indicative of macropinocytosis. No significant co-localization with eGFP-SNX5 was observed for a DiI-labeled control virion possessing the VSV G glycoprotein (DiI-VSVΔ*G-G; Figure 7A, right panel). EbolaΔVP30 particles possessing authentic morphologies (blue bars in Figure 7B) and VSV pseudotyped with EBOV GP (green bars in Figure 7B) co-localized with eGFP-Rab7-positive vesicles with similar kinetics, indicating that the smaller size of the VSV virions relative to that of the Ebola virions did not affect the kinetics of internalization. The kinetics of DiI-VSVΔ*G-G trafficking to late endosomes/lysosomes (red bars in Figure 7B) was consistent with a previous study of authentic VSV [92]. EIPA, which specifically interferes with macropinocytosis, blocked the co-localization of eGFP-Rab7 with DiI-labeled VSVΔ*G-GP (green bars in Figure 7C), but not with DiI-VSVΔ*G-G (red bars in Figure 7C). The PI3K inhibitors significantly reduced the co-localization of eGFP-Rab7 with DiI-labeled VSVΔ*G-GP (green bars in Figure 7C) but not with VSVΔ*G-G (red bars in Figure 7C), which is consistent with previous findings [93].
The effect of these inhibitors was further assessed in a viral infection system by use of a VSV pseudovirion encoding eGFP. Vero cells were pre-treated with one of the inhibitors and then infected with VSVΔG*-GP (green bars in Figure 7D) or VSVΔG*-G (red bars in Figure 7D) in the presence of the inhibitors. The infection efficiency of each pseudovirus was determined by measuring the number of GFP-positive cells. EIPA blocked the infection of VSVΔ*G-GP (green bars in Figure 7D), but not VSVΔ*G-G (red bars in Figure 7D). The PI3K inhibitors reduced the infection of VSVΔ*G-GP (green bars in Figure 7D) but not VSVΔ*G-G (red bars in Figure 7D), which is consistent with the results of the co-localization of DiI-VSV pseudovirions and SNX5 (Figure 7C). These findings demonstrated that in this viral infection system, VSV pseudotyped with EBOV GP is internalized by macropinocytosis, as are EbolaΔVP30 and Ebola VLPs. Therefore, regardless of the size of the virions, our data indicate that EBOV GP induces receptor-dependent macropinocytosis, unlike those in a previous report which showed that macropinocytosis is receptor-independent [32]. Our finding is consistent with a recent report describing receptor-dependent macropinocytosis in adenovirus type 3 [33].
Discussion
Viruses accomplish cell entry by hijacking the cellular endocytic machinery. In this study, with EBOV particles that resemble authentic EBOV, the data lead us to conclude that EBOV is internalized into host cells via macropinocytosis in a viral GP-dependent manner.
Our conclusion that EBOV is internalized via macropinocytosis is based on the following observations: (i) the internalized viral particles co-localize with a marker of macropinosomes, SNX5 (Figure 3); (ii) the internalization of viral particles was blocked by inhibitors of actin polymerization and PI3K, which are known players in macropinocytosis and also by a specific inhibitor of macropinocytosis, EIPA (Figure 5); (iii) the internalization of Ebola virions accelerated the uptake of a specific cargo for macropinosomes Dex Mw 10K (Figure 6A) and the internalized virions co-localized with Dex Mw 10K (Figure 6B); (iv) the internalization of viral particles was blocked by a dominant-negative Rac1 (Figure 6C and 6D), a PKC inhibitor (Figure 6E) and the down-regulation of Cdc42 and Pak1 (Figure 6F and 6G); and (v) the internalization of viral particles was associated with membrane ruffling (Figure 6H). These findings suggest a model in which the binding of EBOV glycoprotein to cellular receptor(s) activates multiple macropinocytosis inducers (PI3K, Rac1, PKC, Cdc42, and Pak1), triggering plasma membrane ruffling and macropinocytosis (Figure 8). Internalized Ebola virions then traffic to Rab7-positive late endosomes/lysosomes (Figure 4), where membrane fusion occurs (Figure 8).
Two findings, the inability to enter cells of Ebola VLPs lacking GP (Figure S2) and the macropinocytic uptake of VSV particles pseudotyped with EBOV GP (Figure 7), support a role for GP in the macropinocytic internalization of EBOV particles. Macropinocytosis was thought to be receptor-independent [32] until a recent study showed that Ad3 entry via macropinocytosis requires receptors (CD46 and integrins) [33]. This finding, together with our observations, supports the concept of receptor-mediated macropinocytic pathways. The exact mechanism of GP-mediated macropinocytosis remains to be elucidated; however, mannose-binding lectin, a potential EBOV co-receptor [43], is known to accelerate macropinocytosis and phagocytosis for the uptake of apoptotic cells and bacteria into macrophages [94], [95]. In addition, integrins, which are also potential EBOV co-receptors [47], play an important role in Ad3 entry via macropinocytosis [33]. Thus, macropinocytosis is likely initiated through GP interaction with EBOV co-receptors on the cell surface (Figure 8).
Recently, one study demonstrated that the entry of Ebola VLPs and pseudovirions depends on the PI3K-Akt signaling pathway and Rac1 [93]. PI3K and its effectors are responsible for ruffling and macropinocytosis [23], [31]. Rac1 is also critical for the induction of actin filament accumulation at the plasma membrane, which leads to membrane ruffling and macropinocytosis [27]. Moreover, membrane-bound Rac1 localizes to macropinosomes [26], [27], [28]. Other study demonstrated that overexpression of RhoC GTPase facilitated wild-type EBOV entry and VSV pseudotyped with EBOV GP [96]. Although a role of RhoC in viral entry has not been specifically characterized, the overexpression of RhoC resulted in increased dextran uptake and in formation of increased actin organization [96], suggesting that RhoC plays a role in EBOV entry mediated via macropinocytosis.
Taken together with our findings, these observations support the model of EBOV entry through macropinocytosis.
Clathrin-mediated endocytosis was thought to contribute to EBOV entry based on findings that specific inhibitors of clathrin-mediated endocytosis blocked the expression of viral antigens in EBOV-infected cells [59]. However, some of these inhibitors caused severe cytotoxicity, which may have induced the down-regulation of viral antigen expression [59]. Recently, by using specific inhibitors of clathrin-mediated endocytosis, a dominant-negative Eps15, which abrogates CCP formation, and siRNA for CHC, a possible role for the clathrin-dependent pathway in the internalization of retrovirus pseudovirions with EBOV GP was suggested [60]. The discrepancy between this study and ours may originate from the difference in pseudotype systems (retrovirus versus VSV or Ebola virions) and specific cell types [60]. Our data demonstrate that down-regulation of cellular CHC, which specifically blocks clathrin-mediated endocytosis, does not interfere with the internalization of Ebola virions which resemble authentic EBOV in their morphology into Vero cells (Figure 1B).
Caveolae- and lipid-raft-mediated endocytosis were also thought to play a role in EBOV entry because FR-α, a potential co-receptor of filovirus entry, localizes to lipid rafts and is internalized through lipid raft-associated caveolae [40]. However, the role of FR-α in EBOV entry remains controversial [51], [97]. The internalization of EBOV GP-pseudotyped virions was sensitive to the depletion of cholesterol, a major component of caveolae and lipid rafts [50], [57], [58]; however, cholesterol is also required for membrane ruffling and macropinocytosis [98]. Moreover, the internalization of Ebola virions into cells transfected with siRNA for Cav1 (Figure 2B and 2C) or that lacked Cav1 (Figure 2D), argues against a role for caveolae-mediated endocytosis in EBOV entry.
One study [59] ruled out macropinocytic uptake of wild-type EBOV based on the use of an amiloride; however, the concentration of the drug used was one tenth of that typically used and may not have allowed the authors to detect an effect of this anti-macropinocytic drug on EBOV internalization.
After internalization, EBOV particles traffic to late endosomes, as suggested by their co-localization with Rab7-positive vesicles (Figure 4). This finding is consistent with previous studies that identified low pH- and cathepsin B/L-requirements for the internalization of EBOV and pseudovirions with EBOV GP into host cells [50], [51], [52], [53], [54], [55], [56].
Currently, no antivirals or vaccines are available for EBOV infections. Since viral entry is an attractive target for therapeutic intervention, it is imperative that we understand the mechanism of EBOV cell entry. Our finding that EBOV is likely internalized through macropinocytosis may stimulate the development of compounds that interfere with the EBOV internalization process.
Materials and Methods
Plasmids and reagents
Human CLCa, Cav1, and Rab7 genes were amplified by RT-PCR from total RNA derived from HeLa cells, and subcloned into pEGFP-N1 or pEGFP-C1 plasmids (Clontech, Mountain View, USA). The eGFP-SNX5 and eGFP-actin expression plasmid was a kind gift from Drs Rohan D. Teasdale (University of Queensland, Brisbane, Australia) and David Knecht (University of Connecticut), respectively. The eGFP-fused genes were cloned into a moloney murine leukemia virus-based retrovirus plasmid [99], a kind gift from Dr. Bill Sugden (University of Wisconsin-Madison, Madison, USA). Expression plasmids for eGFP-fused wild-type and dominant-negative Rac1 were purchased from Addgene (Cambridge, USA). DiI, Alexa Fluor 633-labeled Tf and Alexa Fluor 647-labeled Dex Mw 10K were purchased from Invitrogen (Carlsbad, USA). Dynasore, Cytochalasin D, Wortmannin, LY-294002 hydrochloride, EIPA, and Staurosporine were purchased from Sigma-Aldrich (St. Louis, USA). Antibodies for human clathrin heavy chain and Caveolin 1 were purchased from Abcam (Cambridge, UK).
Cell culture and transfection
African green monkey kidney epithelial Vero cells were grown in minimum essential medium (MEM) supplemented with 10% fetal bovine serum (FBS), L-glutamine, vitamins, nonessential amino acids, and antibiotics. A Vero cell line stably expressing the EBOV VP30 protein [62] was maintained in complete MEM containing 5 µg/ml puromycin (Sigma-Aldrich). Human embryonic kidney 293T cells and human hepatoblastoma cell line Huh7 cells were grown in high-glucose Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS and antibiotics. Cells were maintained at 37°C in 5% CO2. Plasmid transfections in Vero cells were carried out with FuGENE HG (Roche, Basel, Switzerland).
Retroviral infection
Recombinant retroviruses for the expression of CLCa-eGFP, Cav1-eGFP, eGFP-SNX5, -actin and -Rab7, were produced and purified as previously described [99]. For retroviral infections, Vero cells were grown to 20%–30% confluence, at which point the culture medium was replaced with ice-cold MEM supplemented with 10% FBS and 20 mM Hepes (pH 7.4), and the cells were incubated with viral stocks (107–108 infectious units/ml) for 1 h at 4°C at a multiplicity of infection (m.o.i) of 5. After being washed twice with complete medium, the cells were cultured in complete medium for 48 h.
Purification and fluorescent-labeling of viral particles
For the purification of EbolaΔVP30, Vero cells stably expressing VP30 were infected with EbolaΔVP30 stock [62] at a m.o.i of 0.1 in MEM containing 4% BSA and 2% FBS. EbolaΔVP30-containing culture medium was harvested 5 days post-infection and centrifuged at 3,500 rpm for 15 min to remove cell debris. The virions were precipitated through a 30% sucrose cushion by centrifugation at 11,000 rpm for 1 h at 4°C with an SW28 rotor (Beckman, Fullerton, USA). Precipitated virions were resuspended in TNE buffer [10 mM Tris-HCl (pH 7.6), 100 mM NaCl, 1 mM EDTA], and fractionated by use of a 2.5%–30% Nicodenz (Nycomed Pharma AS, Oslo, Norway) gradient in TNE buffer at 27,000 rpm for 2.5 h at 4°C with an SW40 rotor (Beckman). The purification efficiency was confirmed by Coomassie Brilliant Blue staining and western blot analysis with antibodies to VP40 and NP. The infectious titer was determined by plaque assay, as described previously [62].
For purification of Ebola VLPs, equal amounts of the expression plasmids for EBOV VP40 [100], [101], NP [100], and GP [100], [101] were transfected into 293T cells by using TransIT LT-1 (Mirus, Madison, USA). Forty-eight hours post-transfection, the culture supernatants were harvested and released VLPs were purified, as described above. Incorporation of viral proteins in the purified VLPs was confirmed by western blot analysis with antibodies to VP40, GP and NP, and the morphology of the VLPs was confirmed by negative staining (Figure S3).
Influenza virus A/PR/8/34 was prepared and purified as described previously [102]. VSV pseudotyped with EBOV GP (VSVΔG*-GP) was generated as described previously [61] and purified as described above. Protein concentrations of the individual virion fractions were measured by use of a Bradford protein assay kit (BioRad, Hercules, USA).
Viral particles were fluorescently labeled as described by Sakai et al. [67]. Briefly, 1 ml of fractionated virions (100 µg/ml) was incubated with 6 µl of 100 µM stock solution of DiI in the dark for 1 h at room temperature with gentle agitation.
Imaging of the internalization of DiI-labeled viral particles in live cells
For real-time imaging of the internalization of DiI-labeled viral particles, Vero cells expressing CLCa-eGFP, Cav1-eGFP, eGFP-SNX5, eGFP-actin or eGFP-Rab7 were cultured in 35 mm glass-bottom culture dishes (MatTek corporation, Ashland, USA), washed in 1 ml of phenol red-free MEM (Invitrogen) containing 2% FBS and 4% BSA, and incubated with DiI-labeled virions in 50 µl of the same medium on ice for 30 min. The cells were washed with the ice-cold medium and incubated for various times in a temperature-controlled chamber on the stage of a confocal laser scanning microscope (LSM510 META, Carl Zeiss, Oberkochen, Germany); the chamber was maintained at 37°C with a humidified atmosphere of 5% CO2. Images were collected with a 40x oil objective lens (C-Apochromat, NA = 1.2, Carl Zeiss) and acquired by using LSM510 software (Carl Zeiss). For presentation in this manuscript, all images were digitally processed with Adobe Photoshop. For co-localization analysis, the images were acquired randomly, the number of DiI-labeled virions that co-localized with eGFP-SNX5 or eGFP-Rab7-positive vesicles were measured in 10 individual cells (approximately 10–20 dots/cell), and the percentage of co-localization in the total DiI-virions was determined for each time point. Each experiment was performed in triplicate and the results are presented as the mean ± standard deviation.
siRNA treatment
Target sequences corresponding to the human CHC [103], Cav1 [104],and Cdc42 [105] -coding sequences were selected, respectively (Table S1), and synthesized (Dharmacon, Lafayette, USA or Qiagen, Hilden, Germany). siRNA for Pak1 down-regulation was purchased from Cell Signaling (Trask Lane, USA). Synthesized siRNA was transfected into Vero cells by using TransIT-TKO (Mirus, Madison, USA). For analysis of the efficiencies of internalization of Ebola virions, DiI-virions were adsorbed to the siRNA-transfected cells 48 h post-transfection, as described above, and then incubated for 2 h at 37°C. Uninternalized surface-bound virions were removed by the addition of 0.25% trypsin for 5 min at 37°C and the number of DiI-virions in 10 individual cells was counted. Each experiment was performed in triplicate and the results are presented as the mean ± SD.
The efficiency of CHC and Cav1 down-regulation was assessed by immunofluorescent staining with antibodies specific to CHC and Cav1 (Abcam, Cambridge, UK). The down-regulation of endogenous Cav1 was also examined by western blot analysis by using an antibody specific to Cav1 (Abcam). The efficiencies of Cdc42 and Pak1 [106] were assessed by RT-PCR with oligonucleotides to amplify each gene (Table S1).
Inhibitor treatment
Vero cells or Vero cells expressing eGFP-Rab7 cultured in 35 mm glass-bottom culture dishes were pretreated with 100 µM dynasore (Sigma-Aldrich), 2 µM cytochalasin D (Sigma-Aldrich), 50 µM LY294002 hydrochloride (Sigma-Aldrich), 50 nM wortmannin (Sigma-Aldrich), 100 µM EIPA (Sigma-Aldrich) or 100 nM staurosporine (Sigma-Aldrich) for 30 min at 37°C. DiI-labeled virions were adsorbed to the cells for 30 min on ice in the presence of these inhibitors in phenol red-free MEM (Invitrogen) containing 2% FBS and 4% BSA. Cells were then washed with the same medium and incubated for 2 h at 37°C in the presence of the inhibitors. As a control, cells were treated with dimethyl sulfoxide (DMSO, Sigma-Aldrich). Efficiencies of internalization of DiI-labeled viral particles into Vero cells or co-localization of DiI-labeled viral particles with eGFP-Rab7 were analyzed by using confocal laser scanning microscope as described above.
Transferrin and dextran uptake assays
Vero cells treated with dynasore, transiently expressing dominant-negative Rac1, were incubated with DiI-labeled virions on ice for 30 min in MEM containing 2% FBS and 4% BSA. The cells were washed with the same medium and then incubated for 2 h at 37°C. Cells were then incubated with 2 µg/ml Alexa Fluor 633-Tf for 10 min or 0.5 mg/ml Alexa Fluor 647-Dex Mw 10K for 60 min at 37°C. To remove surface-bound labeled virions, Tf, or Dex Mw 10K, the cells were treated with trypsin as described above for 5 min at 37°C. Cells were then washed twice with the same medium and internalized DiI-labeled virions, Tf or Dex Mw 10K were analyzed by use of confocal laser scanning microscope. To assess the effect of staurosporine or the siRNA treatment on fluid phase uptake, after staurosporine pretreatment or 48 h post-transfection of individual siRNAs, Vero cells were incubated with 0.5 mg/ml AlexaFluor 647-Dex Mw 10K, harvested by treating with trypsin, washed twice with ice-cold PBS, and fixed with 4% PBS-buffered paraformaldehyde for 10 min at room temperature. The mean fluorescence intensities in the cells were analyzed by use of flow cytometry (FACSCalibur; Becton Dickinson, Franklin Lakes, USA).
VSV pseudovirion infectivity analysis
VSV pseudotyped with EBOV GP (VSVΔG*-GP) or VSV G (VSVΔG*-G) expressing GFP was generated as described previously [61]. Vero cells were treated with a series of inhibitors for 30 min at 37°C and infected with each virus at a multiplicity of infection (as titrated with Vero cells) of 0.002 to 0.005 in the presence of the inhibitors. 1 h post-infection, surface-bound virions were removed by trypsin as described above and cultured for another 24 h. Infection efficiencies for VSVΔG*-GP or VSVΔG*-G were determined by measuring the number of GFP-positive cells by conventional fluorescent microscope. Each experiment was performed in triplicate and the results are presented as the mean ± SD.
Methods for supporting information files
Methods for supporting information files are described in Text S1.
Supporting Information
Zdroje
1. ConnerSD
SchmidSL
2003 Regulated portals of entry into the cell. Nature 422 37 44
2. SieczkarskiSB
WhittakerGR
2002 Dissecting virus entry via endocytosis. J Gen Virol 83 1535 1545
3. MarshM
HeleniusA
2006 Virus entry: open sesame. Cell 124 729 740
4. MarshM
HeleniusA
1980 Adsorptive endocytosis of Semliki Forest virus. J Mol Biol 142 439 454
5. MatlinKS
ReggioH
HeleniusA
SimonsK
1981 Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 91 601 613
6. MatlinKS
ReggioH
HeleniusA
SimonsK
1982 Pathway of vesicular stomatitis virus entry leading to infection. J Mol Biol 156 609 631
7. VeigaE
CossartP
2005 Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells. Nat Cell Biol 7 894 900
8. VeigaE
CossartP
2006 The role of clathrin-dependent endocytosis in bacterial internalization. Trends Cell Biol 16 499 504
9. PelkmansL
KartenbeckJ
HeleniusA
2001 Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3 473 483
10. StuartLM
EzekowitzRA
2005 Phagocytosis: elegant complexity. Immunity 22 539 550
11. AderemA
UnderhillDM
1999 Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17 593 623
12. ClementC
TiwariV
ScanlanPM
Valyi-NagyT
YueBY
2006 A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol 174 1009 1021
13. GhigoE
KartenbeckJ
LienP
PelkmansL
CapoC
2008 Ameobal pathogen mimivirus infects macrophages through phagocytosis. PLoS Pathog 4 e1000087
14. JonesAT
2007 Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J Cell Mol Med 11 670 684
15. KerrMC
TeasdaleRD
2009 Defining macropinocytosis. Traffic 10 364 371
16. MercerJ
HeleniusA
2009 Virus entry by macropinocytosis. Nat Cell Biol 11 510 520
17. SwansonJA
WattsC
1995 Macropinocytosis. Trends Cell Biol 5 424 428
18. SallustoF
CellaM
DanieliC
LanzavecchiaA
1995 Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182 389 400
19. NorburyCC
ChambersBJ
PrescottAR
LjunggrenHG
WattsC
1997 Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 27 280 288
20. KryskoDV
DeneckerG
FestjensN
GabrielsS
ParthoensE
2006 Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells. Cell Death Differ 13 2011 2022
21. HaiglerHT
McKannaJA
CohenS
1979 Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J Cell Biol 83 82 90
22. DowrickP
KenworthyP
McCannB
WarnR
1993 Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth factor/scatter factor-treated cells. Eur J Cell Biol 61 44 53
23. AmyereM
PayrastreB
KrauseU
Van Der SmissenP
VeithenA
2000 Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. Mol Biol Cell 11 3453 3467
24. DharmawardhaneS
SchurmannA
SellsMA
ChernoffJ
SchmidSL
2000 Regulation of macropinocytosis by p21-activated kinase-1. Mol Biol Cell 11 3341 3352
25. KasaharaK
NakayamaY
SatoI
IkedaK
HoshinoM
2007 Role of Src-family kinases in formation and trafficking of macropinosomes. J Cell Physiol 211 220 232
26. MercerJ
HeleniusA
2008 Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320 531 535
27. RidleyAJ
PatersonHF
JohnstonCL
DiekmannD
HallA
1992 The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70 401 410
28. WestMA
PrescottAR
EskelinenEL
RidleyAJ
WattsC
2000 Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr Biol 10 839 848
29. NorburyCC
2006 Drinking a lot is good for dendritic cells. Immunology 117 443 451
30. LiberaliP
KakkonenE
TuracchioG
ValenteC
SpaarA
2008 The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS. EMBO J 27 970 981
31. ArakiN
JohnsonMT
SwansonJA
1996 A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 135 1249 1260
32. SwansonJA
2008 Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol 9 639 649
33. AmstutzB
GastaldelliM
KalinS
ImelliN
BouckeK
2008 Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J 27 956 969
34. RaghuH
Sharma-WaliaN
VeettilMV
SadagopanS
ChandranB
2009 Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J Virol 83 4895 4911
35. PernetO
PohlC
AinouzeM
KwederH
BucklandR
2009 Nipah virus entry can occur by macropinocytosis. Virology 395 298 311
36. LiuNQ
LossinskyAS
PopikW
LiX
GujuluvaC
2002 Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol 76 6689 6700
37. MarechalV
PrevostMC
PetitC
PerretE
HeardJM
2001 Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol 75 11166 11177
38. MeierO
BouckeK
HammerSV
KellerS
StidwillRP
2002 Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol 158 1119 1131
39. Wool-LewisRJ
BatesP
1998 Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 72 3155 3160
40. ChanSY
EmpigCJ
WelteFJ
SpeckRF
SchmaljohnA
2001 Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 106 117 126
41. AlvarezCP
LasalaF
CarrilloJ
MunizO
CorbiAL
2002 C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76 6841 6844
42. BaribaudF
DomsRW
PohlmannS
2002 The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? Expert Opin Ther Targets 6 423 431
43. JiX
OlingerGG
ArisS
ChenY
GewurzH
2005 Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Gen Virol 86 2535 2542
44. LasalaF
ArceE
OteroJR
RojoJ
DelgadoR
2003 Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans. Antimicrob Agents Chemother 47 3970 3972
45. SimmonsG
ReevesJD
GroganCC
VandenbergheLH
BaribaudF
2003 DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305 115 123
46. TakadaA
FujiokaK
TsuijiM
MorikawaA
HigashiN
2004 Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 78 2943 2947
47. TakadaA
WatanabeS
ItoH
OkazakiK
KidaH
2000 Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278 20 26
48. ShimojimaM
IkedaY
KawaokaY
2007 The mechanism of Axl-mediated Ebola virus infection. J Infect Dis 196 Suppl 2 S259 263
49. ShimojimaM
TakadaA
EbiharaH
NeumannG
FujiokaK
2006 Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 80 10109 10116
50. EmpigCJ
GoldsmithMA
2002 Association of the caveola vesicular system with cellular entry by filoviruses. J Virol 76 5266 5270
51. SimmonsG
RennekampAJ
ChaiN
VandenbergheLH
RileyJL
2003 Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 77 13433 13438
52. BrindleyMA
HughesL
RuizA
McCrayPBJr
SanchezA
2007 Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol 81 7702 7709
53. ChandranK
SullivanNJ
FelborU
WhelanSP
CunninghamJM
2005 Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308 1643 1645
54. KaletskyRL
SimmonsG
BatesP
2007 Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81 13378 13384
55. LeeJE
FuscoML
HessellAJ
OswaldWB
BurtonDR
2008 Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454 177 182
56. SchornbergK
MatsuyamaS
KabschK
DelosS
BoutonA
2006 Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80 4174 4178
57. BavariS
BosioCM
WiegandE
RuthelG
WillAB
2002 Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195 593 602
58. YonezawaA
CavroisM
GreeneWC
2005 Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol 79 918 926
59. SanchezA
2007 Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis 196 Suppl 2 S251 258
60. BhattacharyyaS
WarfieldKL
RuthelG
BavariS
AmanMJ
Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 401 18 28
61. TakadaA
RobisonC
GotoH
SanchezA
MurtiKG
1997 A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94 14764 14769
62. HalfmannP
KimJH
EbiharaH
NodaT
NeumannG
2008 Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A 105 1129 1133
63. KallstromG
WarfieldKL
SwensonDL
MortS
PanchalRG
2005 Analysis of Ebola virus and VLP release using an immunocapture assay. J Virol Methods 127 1 9
64. NodaT
SagaraH
SuzukiE
TakadaA
KidaH
2002 Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol 76 4855 4865
65. WatanabeS
WatanabeT
NodaT
TakadaA
FeldmannH
2004 Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol 78 999 1005
66. LicataJM
JohnsonRF
HanZ
HartyRN
2004 Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. J Virol 78 7344 7351
67. SakaiT
OhuchiM
ImaiM
MizunoT
KawasakiK
2006 Dual wavelength imaging allows analysis of membrane fusion of influenza virus inside cells. J Virol 80 2013 2018
68. Le BlancI
LuyetPP
PonsV
FergusonC
EmansN
2005 Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol 7 653 664
69. LakadamyaliM
RustMJ
BabcockHP
ZhuangX
2003 Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100 9280 9285
70. GaidarovI
SantiniF
WarrenRA
KeenJH
1999 Spatial control of coated-pit dynamics in living cells. Nat Cell Biol 1 1 7
71. MerrifieldCJ
FeldmanME
WanL
AlmersW
2002 Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits. Nat Cell Biol 4 691 698
72. RustMJ
LakadamyaliM
ZhangF
ZhuangX
2004 Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 11 567 573
73. TorgersenML
SkrettingG
van DeursB
SandvigK
2001 Internalization of cholera toxin by different endocytic mechanisms. J Cell Sci 114 3737 3747
74. DammEM
PelkmansL
KartenbeckJ
MezzacasaA
KurzchaliaT
2005 Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol 168 477 488
75. OrthJD
KruegerEW
CaoH
McNivenMA
2002 The large GTPase dynamin regulates actin comet formation and movement in living cells. Proc Natl Acad Sci U S A 99 167 172
76. NewtonAJ
KirchhausenT
MurthyVN
2006 Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci U S A 103 17955 17960
77. KerrMC
LindsayMR
LuetterforstR
HamiltonN
SimpsonF
2006 Visualisation of macropinosome maturation by the recruitment of sorting nexins. J Cell Sci 119 3967 3980
78. LimJP
WangJT
KerrMC
TeasdaleRD
GleesonPA
2008 A role for SNX5 in the regulation of macropinocytosis. BMC Cell Biol 9 58
79. RacoosinEL
SwansonJA
1993 Macropinosome maturation and fusion with tubular lysosomes in macrophages. J Cell Biol 121 1011 1020
80. ChavrierP
PartonRG
HauriHP
SimonsK
ZerialM
1990 Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 62 317 329
81. RybinV
UllrichO
RubinoM
AlexandrovK
SimonI
1996 GTPase activity of Rab5 acts as a timer for endocytic membrane fusion. Nature 383 266 269
82. ItoH
WatanabeS
SanchezA
WhittMA
KawaokaY
1999 Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol 73 8907 8912
83. GiraoH
GeliMI
IdrissiFZ
2008 Actin in the endocytic pathway: from yeast to mammals. FEBS Lett 582 2112 2119
84. WalkerEH
PacoldME
PerisicO
StephensL
HawkinsPT
2000 Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6 909 919
85. KoivusaloM
WelchC
HayashiH
ScottCC
KimM
Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188 547 563
86. WestMA
BretscherMS
WattsC
1989 Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol 109 2731 2739
87. SunX
WhittakerGR
2007 Role of the actin cytoskeleton during influenza virus internalization into polarized epithelial cells. Cell Microbiol 9 1672 1682
88. EhrhardtC
MarjukiH
WolffT
NurnbergB
PlanzO
2006 Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol 8 1336 1348
89. SubausteMC
Von HerrathM
BenardV
ChamberlainCE
ChuangTH
2000 Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas. J Biol Chem 275 9725 9733
90. OmuraS
IwaiY
HiranoA
NakagawaA
AwayaJ
1977 A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J Antibiot (Tokyo) 30 275 282
91. WestphalM
JungbluthA
HeideckerM
MuhlbauerB
HeizerC
1997 Microfilament dynamics during cell movement and chemotaxis monitored using a GFP-actin fusion protein. Curr Biol 7 176 183
92. FengY
PressB
Wandinger-NessA
1995 Rab 7: an important regulator of late endocytic membrane traffic. J Cell Biol 131 1435 1452
93. SaeedMF
KolokoltsovAA
FreibergAN
HolbrookMR
DaveyRA
2008 Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog 4 e1000141
94. OgdenCA
deCathelineauA
HoffmannPR
BrattonD
GhebrehiwetB
2001 C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194 781 795
95. JackDL
LeeME
TurnerMW
KleinNJ
ReadRC
2005 Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages. J Leukoc Biol 77 328 336
96. QuinnK
BrindleyMA
WellerML
KaludovN
KondratowiczA
2009 Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol 83 10176 10186
97. SinnPL
HickeyMA
StaberPD
DyllaDE
JeffersSA
2003 Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 77 5902 5910
98. GrimmerS
van DeursB
SandvigK
2002 Membrane ruffling and macropinocytosis in A431 cells require cholesterol. J Cell Sci 115 2953 2962
99. KennedyG
SugdenB
2003 EBNA-1, a bifunctional transcriptional activator. Mol Cell Biol 23 6901 6908
100. WeissenhornW
2004 Structure of Viral Protein.
Klenk HDFH
Ebola and Marburg Viruses; molecular and cellular biology Norfolk Horizon Bioscience 27 57
101. Neumann GNT
TakadaA
JasenoskyLD
KawaokaY
2004 Roles of Filoviral Matrix- and Glycoproteins in the Viral life Cycle.
KHaFH
Ebola and Marburg Viruses; molecular and cellular biology Norfolk Horizon Bioscience 230 203
102. ImaiM
SugimotoK
OkazakiK
KidaH
1998 Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin. Virus Res 53 129 139
103. MoskowitzHS
YokoyamaCT
RyanTA
2005 Highly cooperative control of endocytosis by clathrin. Mol Biol Cell 16 1769 1776
104. ManninenA
VerkadeP
Le LayS
TorkkoJ
KasperM
2005 Caveolin-1 is not essential for biosynthetic apical membrane transport. Mol Cell Biol 25 10087 10096
105. WilkinsonS
PatersonHF
MarshallCJ
2005 Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat Cell Biol 7 255 261
106. ManavathiB
RayalaSK
KumarR
2007 Phosphorylation-dependent regulation of stability and transforming potential of ETS transcriptional factor ESE-1 by p21-activated kinase 1. J Biol Chem 282 19820 19830
Štítky
Hygiena a epidemiologie Infekční lékařství LaboratořČlánek vyšel v časopise
PLOS Pathogens
2010 Číslo 9
- Diagnostický algoritmus při podezření na syndrom periodické horečky
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Stillova choroba: vzácné a závažné systémové onemocnění
- Perorální antivirotika jako vysoce efektivní nástroj prevence hospitalizací kvůli COVID-19 − otázky a odpovědi pro praxi
- Choroby jater v ordinaci praktického lékaře – význam jaterních testů
Nejčtenější v tomto čísle
- Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens
- The Length of Vesicular Stomatitis Virus Particles Dictates a Need for Actin Assembly during Clathrin-Dependent Endocytosis
- Inhibition of TIR Domain Signaling by TcpC: MyD88-Dependent and Independent Effects on Virulence
- Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes